Related Experiment Videos

Pharyngeal infection with Neisseria gonorrhoeae

Insights

Penicillin G, with or without ampicillin, effectively treated pharyngeal gonorrhea in 86% of patients. Tetracycline and spectinomycin also showed high success rates for this common sexually transmitted infection.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Pharyngeal gonorrhea, caused by Neisseria gonorrhoeae, presents a significant public health challenge.
  • Effective treatment regimens are crucial for eradicating the infection and preventing transmission.

Purpose of the Study:

  • To evaluate the efficacy of different antibiotic treatments for pharyngeal gonorrhea.
  • To assess the success rates of penicillin G, ampicillin, tetracycline, and spectinomycin in treating this infection.

Main Methods:

  • A cohort of 156 patients diagnosed with pharyngeal gonorrhea in 1978 were treated with various antibiotic regimens.
  • Posttreatment cultures were obtained from 115 (74%) patients to assess treatment outcomes.
  • Treatment groups included aqueous procaine penicillin G with or without oral ampicillin, oral tetracycline hydrochloride, and intramuscular spectinomycin hydrochloride.

Main Results:

  • Aqueous procaine penicillin G, with or without oral ampicillin, achieved an 86% success rate in treating pharyngeal gonorrhea.
  • Tetracycline hydrochloride administered orally for five days resulted in negative posttreatment cultures for all seven patients.
  • Spectinomycin hydrochloride showed high efficacy, with 9 out of 12 patients clearing the infection.

Conclusions:

  • Penicillin G-based therapies are effective for pharyngeal gonorrhea.
  • Tetracycline and spectinomycin represent viable alternative treatment options.
  • Concurrent anogenital gonorrhea infections were largely eradicated by the studied treatment schedules.

Related Concept Videos